ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

UNII: P89DR4NY54
Preferred Substance Name: ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

139076-62-3
ADVATE
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN FREE METHOD
ANTIHEMOPHILIC FACTOR, HUM REC
ANTIHEMOPHILIC FACTOR, RECOMBINANT
ANTIHEMOPHILIC FACTOR, RECOMBINANT, MANUFACTURED PROTEIN-FREE
ANTIHEMOPHILIC FACTOR,RECOMBINANT
ANTIHEMOPHILIC FACTOR,RECOMBINANT [VANDF]
BAY 14-2222
BAY 81-8973
BAY W 6240
BAY-14-2222
BAY81-8973
BAY-81-8973
BAY-W-6240
BLOOD COAGULATION FACTOR VIII HUMAN, GLYCOFORM .ALPHA.
FACTOR VIII (RDNA)
FACTOR VIII OCTOCOG ALFA [MI]
FACTOR VIII RECOMBIN
FACTOR VIII, RECOMBINANT [WHO-DD]
HELIXATE FS
HELIXATE NEXTGEN
HUMAN FACTOR VIII RECOMBINANT
KOGENATE
KOGENATE BAYER
KOGENATE FS
KOVALTRY
OCTOCOG ALFA
OCTOCOG ALFA [EMA EPAR]
OCTOCOG ALFA [INN]
OCTOCOG ALFA [JAN]
OCTOCOG ALFA [WHO-DD]
RECOMBINANT ANTIHEMOPHILIC FACTOR PREPARATION
RECOMBINANT ANTIHEMOPHILIC FACTOR VIII
RECOMBINATE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by